CalciMedica, Inc. (CALC)

PriceLoading quote

Financial charts

Revenue

No reported data

Net income

Free cash flow

Total cash / debt

CashTotal debt

Financial statements

7 annual periodsNewest to oldest
2025202420232022202120202019
Research & development$15.2M$14.5M$15.9M$8.3M$18.9M$21.0M$30.6M
Operating expenses$23.1M$24.2M$38.1M$14.2M$35.9M$29.8M$37.5M
Operating income−$23.1M−$24.2M−$38.1M−$14.2M−$35.9M−$29.8M−$37.5M
EBITDAderived−$38.0M−$14.1M
Net income−$29.6M−$13.7M−$34.4M−$7.8M−$35.8M−$27.5M−$37.0M
Basic EPSper diluted share-$1.97-$1.22-$7.66-$111.16-$1.69-$5.25-$33.41
Diluted EPSper diluted share-$1.97-$1.22-$7.66-$111.16-$1.69-$5.25-$33.41

Insider buys & sells

Jul 1, 2024Jun 30, 2026
Buys47$2.13M disclosed value
Sells (SEC code S)1$3.6K disclosed value
48 recent transactions
TransactionInsiderTypeSharesPriceValueOwned after
Jun 25, 2026Form 4Middleton Fred ADirector,TenPercentOwnerBuyCommon Stock · indirect249.0K$0.80$199.2K1.06M
Sep 18, 2025Form 4Roberts Eric WCHIEF BUSINESS OFFICERBuyCommon Stock · indirect2.5K$3.07$7.7K84.2K
Sep 15, 2025Form 4Roberts Eric WCHIEF BUSINESS OFFICERBuyCommon Stock · indirect3.4K$2.68$9.1K81.7K
Sep 12, 2025Form 4Roberts Eric WCHIEF BUSINESS OFFICERBuyCommon Stock · indirect5.0K$3.12$15.6K78.3K
Sep 9, 2025Form 4Roberts Eric WCHIEF BUSINESS OFFICERBuyCommon Stock · indirect2.3K$3.15$7.4K73.3K